IFCCA Magazine – October 2026

We are pleased to announce the launch of Module 3 of the Horizon Europe IFCCA Academy: “Basics of Health Technology Assessment (HTA) and its application to RNA-based medicines for Crohn’s disease within the GENEGUT project.”

We invite you to share your perspective in a survey on the education and support people living with Inflammatory Bowel Disease (IBD) need to manage their health and diet.

After several years of collaboration, a global patient preference study conducted in partnership with the International Federation of Crohn's & Ulcerative Colitis Associations (IFCCA) and KU Leuven (Belgium) has been published, providing new insights into what people living with Inflammatory Bowel Disease (IBD) value most when choosing treatments.

The World IBD Day 2026 Conference Report is now available, capturing the key discussions, insights and recommendations from the International World IBD Day Roundtable and Asia-Pacific Networking Meeting held in Singapore on 16 May 2026.